Sen. Judd Gregg’s decision to drop of out the running for the top Business Roundtable job won’t derail the trade association’s hunt for a new president and CEO.
“It is going according to plan and should be done within the next few weeks,” a source familiar with the search said.
On Friday, the New Hampshire Republican told Roll Call he is no longer in consideration for the position, saying in a statement that “although I have the highest regard for the Business Roundtable and believe that it is a positive and constructive voice for good governance in Washington, I do not plan to join this organization.”
Gregg’s decision to bow out leaves a handful of known candidates in the mix, including Larry Burton and Johanna Schneider, who are running the organization on an interim basis. Retiring Blue Dog Coalition Reps. John Tanner and Bart Gordon, both Tennessee Democrats, are also considered likely contenders.
The organization may choose to look off Capitol Hill for a replacement to John Castellani, who left last summer to become president and CEO at the Pharmaceutical Research and Manufacturers of America.
With the new session approaching, K Street has been snapping up Republican staffers on Capitol Hill. The latest move is a top health policy adviser to the Senate Finance Committee’s ranking member taking a job with the lobbying firm of Peck, Madigan, Jones & Stewart Inc.
Andrew McKechnie, who worked for Sen. Chuck Grassley (R-Iowa), will be joining the boutique shop Jan. 3.
“As implementation of the new health care law goes into full swing, we could not be more pleased to add one of the Hill’s foremost experts,” PMJ partner Peter Madigan said in a release issued by the firm.
McKechnie has handled various issues related to the Medicare drug program and the Medicare Advantage plans, Madigan said.
According to third-quarter lobbying reports filed with the Senate, PMJ counts among its clients some of the biggest players on health care issues, including PhRMA and health insurance company Wellpoint. It also lobbies for the biotechnology company Amgen and the drug company AstraZeneca, as well as the Alliance for Quality Nursing Home Care.
Swinging the Other Way
The revolving door is also spinning the other direction. Brett Loper, an Advanced Medical Technology Association lobbyist and former House leadership staffer, will return to the Hill to join the team of Speaker-designate John Boehner (R-Ohio) as policy director next year.
Loper will replace Policy Director Mike Sommers, who will serve as deputy chief of staff for leadership operations in the 112th Congress. The new roles will take effect Jan. 3.
Loper held many top-level staff positions during his tenure on the Hill, including staff director for the House Ways and Means Committee, chief of staff for then-Rep. Jim McCrery (R-La.), and chief of staff for then-Majority Leader Tom DeLay (R-Texas).
Loper briefly worked for Boehner in 2006 after the Ohio Republican won the Majority Leader position following DeLay’s resignation.
Roll Call has launched a new feature, Hill Navigator, to advise congressional staffers and would-be staffers on how to manage workplace issues on Capitol Hill. Please send us your questions anything from office etiquette, to handling awkward moments, to what happens when the work life gets too personal. Submissions will be treated anonymously.